Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 777 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Filana Therapeutics, Inc.
Market Cap
$40.22M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.09M
Net Profit Margin
-689.20%
TTM Avg
-248.90%
3Y Avg
-225.94%
5Y Avg
-1945.52%
Market Cap
$39.84M
Net Profit Margin
8.38%
TTM Avg
3.43%
3Y Avg
-19.55%
5Y Avg
-29.01%
Market Cap
$38.88M
Net Profit Margin
-11.86%
TTM Avg
-39.34%
3Y Avg
-22.53%
5Y Avg
-16.34%
Market Cap
$41.92M
Net Profit Margin
-4.42%
TTM Avg
-14.19%
3Y Avg
-49.13%
5Y Avg
-77.93%
Market Cap
$37.74M
Net Profit Margin
0.00%
TTM Avg
-27258.72%
3Y Avg
-52085.61%
5Y Avg
-35139.97%
Market Cap
$37.67M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-322.60%
Market Cap
$43.17M
Net Profit Margin
32.60%
TTM Avg
-34.66%
3Y Avg
-64.33%
5Y Avg
-204.90%
Market Cap
$37.06M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $40.22M | 0.00% | 0.00% | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.09M | -689.20% | -248.90% | -225.94% | -1945.52% |
| Nephros, Inc. (NEPH)vs › | $39.84M | 8.38% | 3.43% | -19.55% | -29.01% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.88M | -11.86% | -39.34% | -22.53% | -16.34% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -4.42% | -14.19% | -49.13% | -77.93% |
| Incannex Healthcare Limited (IXHL)vs › | $37.74M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.67M | 0.00% | 0.00% | 0.00% | -322.60% |
| SANUWAVE Health Inc. (SNWV)vs › | $43.17M | 32.60% | -34.66% | -64.33% | -204.90% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $37.06M | 0.00% | 0.00% | 0.00% | -479.12% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.83M | -747.20% | -525.22% | -722.73% | -1271.67% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
